Has Ashok Tripuraneni received payments from drug or device companies?

Yes. Drug and device makers reported $6,743 in general payments to Ashok Tripuraneni across 358 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ashok Tripuraneni did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ashok Tripuraneni come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ashok Tripuraneni

Hematology & Oncology · Wapakoneta, OHNPI 1336190610

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,785 of the $6,743 with a category attached, or 85.8%. 43 manufacturers reported payments, led by Amgen at 25.5% of the total. Reporting peaked in 2022 at $1,971 and has fallen 81.8% since, to $359 in 2023.

$6,743in general payments, 2019–2025

Across 358 payments — averaging $18.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$2K
Johnson & Johnson$702
Incyte Corporation$498
Novartis$315
AstraZeneca$287
Merck$260
plus $3K from 37 others

What the payments were for

Food & beverage$5,78586%
Education$95814%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen	95	$1,719
Johnson & Johnson(2 entities)	35	$702
Incyte Corporation	21	$498
Novartis	20	$315
AstraZeneca(2 entities)	11	$287
Merck	15	$260
Pfizer	14	$235
Sanofi-aventis U.S. LLC	3	$216
AMAG Pharmaceuticals, Inc.	13	$208
E.r. Squibb & Sons, L.L.C.	11	$206
Bristol Myers Squibb	12	$185
Coherus Oncology, Inc.	7	$175
Sanofi	10	$167
Jazz Pharmaceuticals Inc.	9	$160
Actelion Pharmaceuticals US, Inc.	1	$125
Daiichi Sankyo Inc.	8	$118
Pharmacyclics LLC, An Abbvie Company	6	$96
Boehringer Ingelheim	6	$91
Rigel Pharmaceuticals, Inc.	5	$90
Lilly USA, LLC	6	$85
Regeneron Healthcare Solutions, Inc.	4	$76
Morphosys, US Inc.	4	$68
Genentech USA, Inc.	4	$61
GSK	4	$58
Seagen Inc.	2	$57
Servier Pharmaceuticals LLC	4	$52
Tersera Therapeutics LLC	3	$51
Blueprint Medicines Corporation	3	$50
G1 Therapeutics, Inc.	2	$43
Bayer	3	$41
Adaptive Biotechnologies Corporation	2	$31
Dova Pharmaceuticals	2	$31
Gilead(2 entities)	2	$29
Deciphera Pharmaceuticals Inc.	2	$25
Array Biopharma Inc	1	$22
Epizyme, Inc.	1	$17
Pharmaessentia USA Corporation	1	$16
Mylan Institutional Inc.	1	$15
Boston Scientific	1	$14
ADC Therapeutics America, Inc.	1	$14
Helsinn Therapeutics (U.S.), Inc.	1	$13
Clovis Oncology, Inc.	1	$12
Teva Pharmaceuticals USA, Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

FASENRA$125

How this compares

$6,743 in reported general payments places this provider in the 65th percentile of 450 hematology & oncology providers in Ohio.

See all hematology & oncology providers in Ohio →

Other hematology & oncology in Wapakoneta

Hillard LazarusCleveland$2M
Kasra KaramlouSandusky$1.8M
David WaterhouseCincinnati$1.3M
Taral PatelColumbus$888K
Tarek ChidiacColumbus$765K
Saulius GirniusMontgomery$707K
Ronald BukowskiCleveland$594K
Balazs HalmosCleveland$568K
Jorge GarciaCleveland$513K
Alejandro CalvoKettering$463K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →